Literature DB >> 25617505

Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease.

Norelle R Reilly1, Benjamin Lebwohl2, Rolf Hultcrantz3, Peter H R Green4, Jonas F Ludvigsson5.   

Abstract

BACKGROUND & AIMS: Non-alcoholic fatty liver disease is a common cause of chronic liver disease. Celiac disease alters intestinal permeability and treatment with a gluten-free diet often causes weight gain, but so far there are few reports of non-alcoholic fatty liver disease in patients with celiac disease.
METHODS: Population-based cohort study. We compared the risk of non-alcoholic fatty liver disease diagnosed from 1997 to 2009 in individuals with celiac disease (n = 26,816) to matched reference individuals (n = 130,051). Patients with any liver disease prior to celiac disease were excluded, as were individuals with a lifetime diagnosis of alcohol-related disorder to minimize misclassification of non-alcoholic fatty liver disease. Cox regression estimated hazard ratios for non-alcoholic fatty liver disease were determined.
RESULTS: During 246,559 person-years of follow-up, 53 individuals with celiac disease had a diagnosis of non-alcoholic fatty liver disease (21/100,000 person-years). In comparison, we identified 85 reference individuals diagnosed with non-alcoholic fatty liver disease during 1,488,413 person-years (6/100,000 person-years). This corresponded to a hazard ratio of 2.8 (95% CI 2.0-3.8), with the highest risk estimates seen in children (HR = 4.6; 95% CI 2.3-9.1). The risk increase in the first year after celiac disease diagnosis was 13.3 (95% CI 3.5-50.3) but remained significantly elevated even beyond 15 years after the diagnosis of celiac disease (HR = 2.5; 95% CI 1.0-5.9).
CONCLUSION: Individuals with celiac disease are at increased risk of non-alcoholic fatty liver disease compared to the general population. Excess risks were highest in the first year after celiac disease diagnosis, but persisted through 15 years after diagnosis with celiac disease.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune; Celiac disease; Gluten; NAFLD; NASH; Steatohepatitis

Mesh:

Year:  2015        PMID: 25617505      PMCID: PMC4439270          DOI: 10.1016/j.jhep.2015.01.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  42 in total

1.  Luminal bacteria and small-intestinal permeability.

Authors:  S M Riordan; C J McIver; D H Thomas; V M Duncombe; T D Bolin; M C Thomas
Journal:  Scand J Gastroenterol       Date:  1997-06       Impact factor: 2.423

2.  Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease.

Authors:  Alberto Rubio-Tapia; Susan H Barton; Jon E Rosenblatt; Joseph A Murray
Journal:  J Clin Gastroenterol       Date:  2009-02       Impact factor: 3.062

Review 3.  Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis.

Authors:  Martine Heyman; Juliette Abed; Corinne Lebreton; Nadine Cerf-Bensussan
Journal:  Gut       Date:  2011-09-02       Impact factor: 23.059

4.  Celiac disease in normal-weight and overweight children: clinical features and growth outcomes following a gluten-free diet.

Authors:  Norelle Rizkalla Reilly; Kathleen Aguilar; Benjamin G Hassid; Jianfeng Cheng; Amy R Defelice; Philip Kazlow; Govind Bhagat; Peter H Green
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-11       Impact factor: 2.839

5.  Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity.

Authors:  Valentina Giorgio; Luca Miele; Luigi Principessa; Francesca Ferretti; Maria Pia Villa; Valentina Negro; Antonio Grieco; Anna Alisi; Valerio Nobili
Journal:  Dig Liver Dis       Date:  2014-03-12       Impact factor: 4.088

6.  Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.

Authors:  Heather M Patton; Katherine Yates; Aynur Unalp-Arida; Cynthia A Behling; Terry T-K Huang; Philip Rosenthal; Arun J Sanyal; Jeffrey B Schwimmer; Joel E Lavine
Journal:  Am J Gastroenterol       Date:  2010-04-06       Impact factor: 10.864

7.  The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran.

Authors:  Ali Reza Rahimi; Nasser Ebrahimi Daryani; Hadi Ghofrani; Mohammad Taher; Mohammad Reza Pashaei; Sina Abdollahzade; Mohammad Kalani; Hosein Ajdarkosh
Journal:  Turk J Gastroenterol       Date:  2011-06       Impact factor: 1.852

8.  Small-intestinal histopathology and mortality risk in celiac disease.

Authors:  Jonas F Ludvigsson; Scott M Montgomery; Anders Ekbom; Lena Brandt; Fredrik Granath
Journal:  JAMA       Date:  2009-09-16       Impact factor: 56.272

9.  The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease.

Authors:  Aikaterini Margariti; Melanie Deutsch; Spilios Manolakopoulos; Dina Tiniakos; George V Papatheodoridis
Journal:  J Clin Gastroenterol       Date:  2013-03       Impact factor: 3.062

Review 10.  Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.

Authors:  N J Barshop; C B Sirlin; J B Schwimmer; J E Lavine
Journal:  Aliment Pharmacol Ther       Date:  2008-04-04       Impact factor: 8.171

View more
  27 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 2.  The Liver and Celiac Disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Clin Liver Dis       Date:  2019-03-01       Impact factor: 6.126

3.  The Connection between Celiac Disease and Hepatic Steatosis: High Levels of Pigment Epithelium-Derived Factor.

Authors:  Okan Dikker; Hüseyin Dağ
Journal:  Med Princ Pract       Date:  2019-09-25       Impact factor: 1.927

Review 4.  Liver involvement in pediatric celiac disease.

Authors:  Caterina Anania; Ester De Luca; Giovanna De Castro; Claudio Chiesa; Lucia Pacifico
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

5.  Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population.

Authors:  Natalia E Castillo; Rohini R Vanga; Thimmaiah G Theethira; Alberto Rubio-Tapia; Joseph A Murray; Javier Villafuerte; Alan Bonder; Rupa Mukherjee; Joshua Hansen; Melinda Dennis; Ciaran P Kelly; Daniel A Leffler
Journal:  Am J Gastroenterol       Date:  2015-07-07       Impact factor: 10.864

6.  The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis.

Authors:  Anas Renno; Yousef Abdel-Aziz; Yaseen Alastal; Sadik Khuder; Syed Hasan; Ragheb Assaly; Ali Nawras
Journal:  Clin Exp Hepatol       Date:  2021-03-25

7.  Coeliac disease and invasive pneumococcal disease: a population-based cohort study.

Authors:  A Röckert Tjernberg; J Bonnedahl; M Inghammar; A Egesten; G Kahlmeter; P Nauclér; B Henriques-Normark; J F Ludvigsson
Journal:  Epidemiol Infect       Date:  2017-01-23       Impact factor: 4.434

Review 8.  Celiac Disease: Extraintestinal Manifestations and Associated Conditions.

Authors:  Amelie Therrien; Ciaran P Kelly; Jocelyn A Silvester
Journal:  J Clin Gastroenterol       Date:  2020-01       Impact factor: 3.174

9.  A novel biomarker for prediction of atrial fibrillation susceptibility in patients with celiac disease.

Authors:  Selcuk Kucukseymen; Ayhan Hilmi Cekin; Nermin Bayar; Sakir Arslan; Elif Uygur Kucukseymen; Tanju Mercan; Semir Ozdemir
Journal:  PLoS One       Date:  2018-01-09       Impact factor: 3.240

10.  Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.

Authors:  Atsuko Nakatsuka; Makoto Matsuyama; Satoshi Yamaguchi; Akihiro Katayama; Jun Eguchi; Kazutoshi Murakami; Sanae Teshigawara; Daisuke Ogawa; Nozomu Wada; Tetsuya Yasunaka; Fusao Ikeda; Akinobu Takaki; Eijiro Watanabe; Jun Wada
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.